{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:22:34Z","timestamp":1790446954645,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.pdpdt.2025.104632","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T11:55:39Z","timestamp":1747396539000},"page":"104632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Systematic review and network meta-analysis of retinal imaging biomarkers in neurodegenerative diseases: Correlation with brain changes"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3119-1180","authenticated-orcid":false,"given":"Farzaneh","family":"Nikparast","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Ganji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nooshin","family":"Akbari-Sharak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2025.104632_bib0001","doi-asserted-by":"crossref","unstructured":"Martin Joseph B. Molecular basis of the neurodegenerative disorders. New England J. Med..340(25):1970\u201380.","DOI":"10.1056\/NEJM199906243402507"},{"issue":"8","key":"10.1016\/j.pdpdt.2025.104632_bib0002","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/jnnp.2004.060186","article-title":"Neurodegenerative disorders: parkinson's disease and Huntington's disease","volume":"76","author":"Hague","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104632_bib0003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/NEN.0000000000000144","article-title":"Spectrum of neuropathophysiology in spinal muscular atrophy type I","volume":"74","author":"Harding","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104632_bib0004","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","article-title":"Spinocerebellar ataxia","volume":"5","author":"Klockgether","year":"2019","journal-title":"Nat. Rev. Disease Primers"},{"issue":"6","key":"10.1016\/j.pdpdt.2025.104632_bib0005","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","article-title":"Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration","volume":"68","author":"Hoover","year":"2010","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.pdpdt.2025.104632_bib0006","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tins.2010.08.002","article-title":"Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease","volume":"33","author":"Milnerwood","year":"2010","journal-title":"Trends Neurosci."},{"issue":"24","key":"10.1016\/j.pdpdt.2025.104632_bib0007","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1523\/JNEUROSCI.1091-10.2010","article-title":"A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration","volume":"30","author":"Scott","year":"2010","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104632_bib0008","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"23","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pdpdt.2025.104632_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8503859","article-title":"Optical coherence tomography as a biomarker for diagnosis, progression, and prognosis of neurodegenerative diseases","volume":"2016","author":"Satue","year":"2016","journal-title":"J. Ophthalmol."},{"issue":"10423","key":"10.1016\/j.pdpdt.2025.104632_bib0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","article-title":"Medical, surgical, and physical treatments for Parkinson's disease","volume":"403","author":"Foltynie","year":"2024","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.pdpdt.2025.104632_bib0011","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S1474-4422(18)30409-5","article-title":"Will Europe be ready for the treatment of Alzheimer's disease?","volume":"17","year":"2018","journal-title":"Lancet Neurol."},{"issue":"10284","key":"10.1016\/j.pdpdt.2025.104632_bib0012","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104632_bib0013","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/ph11020044","article-title":"Old drugs as new treatments for neurodegenerative diseases","volume":"11","author":"Dur\u00e3es","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.pdpdt.2025.104632_bib0014","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-clinpsy-050212-185535","article-title":"Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection","volume":"9","author":"Risacher","year":"2013","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104632_bib0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13244-022-01207-6","article-title":"Brain pathological changes during neurodegenerative diseases and their identification methods: how does QSM perform in detecting this process?","volume":"13","author":"Nikparast","year":"2022","journal-title":"Insights ImAging"},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104632_bib0016","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12868-022-00725-9","article-title":"Early differentiation of neurodegenerative diseases using the novel QSM technique: what is the biomarker of each disorder?","volume":"23","author":"Nikparast","year":"2022","journal-title":"BMC. Neurosci."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104632_bib0017","first-page":"130","article-title":"Application of Nobel QSM technique in MRI for diagnosis of Alzheimer's disease: what is the relationship between iron deposits in brain nuclei with age and severity of disorders?","volume":"45","author":"Nikparast","year":"2023","journal-title":"Med. J. Tabriz. Uni. Med. Sci"},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104632_bib0018","first-page":"45","article-title":"Brain nucleus changes in cognitive disorders: examining by the quantitative susceptibility mapping (QSM) technique","volume":"21","author":"Nikparast","year":"2024","journal-title":"Iran. J. Med. Phys."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104632_bib0019","first-page":"194","article-title":"A follow-up study investigating the spectrum of cognitive impairment by MRI: does iron cause cognitive dysfunction or vice versa?","volume":"21","author":"Nikparast","year":"2024","journal-title":"Iran. J. Med. Phys."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104632_bib0020","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer\u2019s disease","volume":"82","author":"Spires-Jones Tara","year":"2014","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.pdpdt.2025.104632_bib0021","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-016-1571-z","article-title":"Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease","volume":"131","author":"Kalaria","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"1\u20132","key":"10.1016\/j.pdpdt.2025.104632_bib0022","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2004.09.003","article-title":"MRI and CT in the diagnosis of vascular dementia","volume":"226","author":"Van Straaten","year":"2004","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104632_bib0023","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000531088","article-title":"Imaging, genetic, and pathological features of vascular dementia","volume":"86","author":"Yang","year":"2023","journal-title":"Eur. Neurol."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104632_bib0024","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ana.22592","article-title":"Seven-tesla magnetic resonance images of the substantia nigra in Parkinson disease","volume":"71","author":"Kwon","year":"2012","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.pdpdt.2025.104632_bib0025","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1212\/WNL.0b013e31829e6fd2","article-title":"Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI","volume":"81","author":"Blazejewska","year":"2013","journal-title":"Neurology."},{"issue":"5","key":"10.1016\/j.pdpdt.2025.104632_bib0026","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/mds.26584","article-title":"Loss of nigral hyperintensity on 3 tesla MRI of parkinsonism: comparison with (123) I-FP-CIT SPECT","volume":"31","author":"Bae","year":"2016","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104632_bib0027","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3174\/ajnr.A4158","article-title":"Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease","volume":"36","author":"Cosottini","year":"2015","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"7","key":"10.1016\/j.pdpdt.2025.104632_bib0028","first-page":"1307","article-title":"Universality analysis of the existence of substantia nigra \"swallow tail\" appearance of non-parkinson patients in 3T SWI","volume":"20","author":"Gao","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104632_bib0029","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/mds.26932","article-title":"Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease","volume":"32","author":"Mahlknecht","year":"2017","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104632_bib0030","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/jmri.25553","article-title":"Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI)","volume":"46","author":"Nam","year":"2017","journal-title":"J. Magn. Reson. Imaging"},{"issue":"11","key":"10.1016\/j.pdpdt.2025.104632_bib0031","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3174\/ajnr.A4412","article-title":"Nigrosome 1 detection at 3T MRI for the diagnosis of early-stage idiopathic Parkinson disease: assessment of diagnostic accuracy and agreement on imaging asymmetry and clinical laterality","volume":"36","author":"Noh","year":"2015","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"5","key":"10.1016\/j.pdpdt.2025.104632_bib0032","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2214\/AJR.16.16092","article-title":"Correlation of 3D FLAIR and dopamine transporter imaging in patients with Parkinsonism","volume":"207","author":"Oh","year":"2016","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.pdpdt.2025.104632_bib0033","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clinimag.2017.04.005","article-title":"Can loss of the swallow tail sign help distinguish between Parkinson Disease and the Parkinson-Plus syndromes?","volume":"44","author":"Oustwani","year":"2017","journal-title":"Clin. Imaging"},{"issue":"8","key":"10.1016\/j.pdpdt.2025.104632_bib0034","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/mds.26171","article-title":"Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative parkinsonism","volume":"30","author":"Reiter","year":"2015","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104632_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093814","article-title":"The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T","volume":"9","author":"Schwarz","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104632_bib0036","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1148\/radiol.2015151466","article-title":"Drug-induced parkinsonism versus idiopathic Parkinson Disease: utility of nigrosome 1 with 3-T imaging","volume":"279","author":"Sung","year":"2016","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.pdpdt.2025.104632_bib0037","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1007\/s00330-017-4743-x","article-title":"Using 'swallow-tail' sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson's disease: a susceptibility-weighted imaging study","volume":"27","author":"Wang","year":"2017","journal-title":"Eur. Radiol."},{"issue":"7","key":"10.1016\/j.pdpdt.2025.104632_bib0038","first-page":"392","article-title":"A follow-up study on brainstem atrophy in progressive supranuclear palsy\u2013when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?","volume":"43","author":"Yamamoto","year":"2003","journal-title":"Rinsho Shinkeigaku"},{"issue":"5594","key":"10.1016\/j.pdpdt.2025.104632_bib0039","first-page":"789","article-title":"Alzheimer's Disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science (1979)"},{"issue":"11","key":"10.1016\/j.pdpdt.2025.104632_bib0040","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","article-title":"Imaging the evolution and pathophysiology of Alzheimer disease","volume":"19","author":"Jagust","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104632_bib0041","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2009.03.024","article-title":"Neurodegenerative diseases target large-scale Human brain networks","volume":"62","author":"Seeley","year":"2009","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.pdpdt.2025.104632_bib0042","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-\u03b2\u2013induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pdpdt.2025.104632_bib0043","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.parkreldis.2018.12.016","article-title":"Resting-state fMRI in Parkinson's disease patients with cognitive impairment: a meta-analysis","volume":"62","author":"Wolters","year":"2019","journal-title":"Parkinsonism. Relat. Disord."},{"issue":"9","key":"10.1016\/j.pdpdt.2025.104632_bib0044","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1002\/hbm.25369","article-title":"Diagnostic power of resting-state fMRI for detection of network connectivity in Alzheimer's disease and mild cognitive impairment: a systematic review","volume":"42","author":"Ibrahim","year":"2021","journal-title":"Hum. Brain Mapp."},{"issue":"12","key":"10.1016\/j.pdpdt.2025.104632_bib0045","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.diii.2013.06.010","article-title":"Arterial spin labeling (ASL) perfusion: techniques and clinical use","volume":"94","author":"Ferr\u00e9","year":"2013","journal-title":"Diagn. Interv. ImAging"},{"key":"10.1016\/j.pdpdt.2025.104632_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.diii.2013.06.010","article-title":"Arterial spin labeling (ASL) perfusion: techniques and clinical use","volume":"94","author":"Ferr\u00e9","year":"2013","journal-title":"Diagn. Interv. ImAging"},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104632_bib0047","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3233\/JAD-200034","article-title":"Cerebral blood flow is associated with diagnostic class and cognitive decline in Alzheimer's disease","volume":"76","author":"Duan","year":"2020","journal-title":"J. Alzheimers. Dis."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104632_bib0048","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.neuroimage.2008.06.006","article-title":"Press DZ. Hippocampal hyperperfusion in Alzheimer's disease","volume":"42","author":"Alsop","year":"2008","journal-title":"Neuroimage"},{"issue":"Suppl 3(0)","key":"10.1016\/j.pdpdt.2025.104632_bib0049","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.3233\/JAD-2012-120292","article-title":"Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study","volume":"31","author":"Bangen","year":"2012","journal-title":"J. Alzheimers. Dis."},{"issue":"11","key":"10.1016\/j.pdpdt.2025.104632_bib0050","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.neurobiolaging.2008.01.012","article-title":"Cerebral perfusion and oxygenation differences in Alzheimer's disease risk","volume":"30","author":"Fleisher","year":"2009","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104632_bib0051","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1148\/radiol.2503080751","article-title":"Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging","volume":"250","author":"Dai","year":"2009","journal-title":"Radiology."},{"issue":"46","key":"10.1016\/j.pdpdt.2025.104632_bib0052","doi-asserted-by":"crossref","first-page":"18008","DOI":"10.1523\/JNEUROSCI.1402-13.2013","article-title":"Changes in brain function occur years before the onset of cognitive impairment","volume":"33","author":"Beason-Held","year":"2013","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.pdpdt.2025.104632_bib0053","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1515\/revneuro-2015-0010","article-title":"Magnetic resonance spectroscopy of the brain: a review of physical principles and technical methods","volume":"26","author":"Buonocore","year":"2015","journal-title":"Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104632_bib0054","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","article-title":"The retina as a window to the brain\u2014From eye research to CNS disorders","volume":"9","author":"London","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pdpdt.2025.104632_bib0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fncel.2016.00020","article-title":"Brain and retinal pericytes: origin, function and role","volume":"10","author":"Trost","year":"2016","journal-title":"Front. Cell Neurosci."},{"issue":"9","key":"10.1016\/j.pdpdt.2025.104632_bib0056","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1167\/iovs.13-12046","article-title":"Evaluation of retinal nerve Fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography","volume":"54","author":"Marziani","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pdpdt.2025.104632_bib0057","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.preteyeres.2018.07.002","article-title":"Sadda SR. OCT angiography and evaluation of the choroid and choroidal vascular disorders","volume":"67","author":"Borrelli","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"issue":"7","key":"10.1016\/j.pdpdt.2025.104632_bib0058","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.clineuro.2011.02.014","article-title":"Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease","volume":"113","author":"Kesler","year":"2011","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104632_bib0059","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajo.2013.09.028","article-title":"Distribution of retinal layer atrophy in patients with Parkinson Disease and association with disease severity and duration","volume":"157","author":"Garcia-Martin","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2025.104632_bib0060","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.pdpdt.2025.104632_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2024.111537","article-title":"Network meta-analysis: a powerful tool for clinicians, decision-makers, and methodologists","volume":"176","author":"Florez","year":"2024","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104632_bib0062","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13195-019-0516-x","article-title":"Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer's disease","volume":"11","author":"den Haan","year":"2019","journal-title":"Alzheimers. Res. Ther."},{"issue":"41","key":"10.1016\/j.pdpdt.2025.104632_bib0063","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.1523\/JNEUROSCI.0379-23.2023","article-title":"Synaptic compensatory plasticity in Alzheimer's disease","volume":"43","author":"Bhembre","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pdpdt.2025.104632_bib0064","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.dadm.2019.04.003","article-title":"Perifovea retinal thickness as an ophthalmic biomarker for mild cognitive impairment and early Alzheimer's disease","volume":"11","author":"Tao","year":"2019","journal-title":"Alzheimers. Dement. (Amst)"},{"issue":"6","key":"10.1016\/j.pdpdt.2025.104632_bib0065","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1007\/s00415-021-10936-5","article-title":"Peripapillary retinal nerve fiber layer thinning in patients with progressive supranuclear palsy","volume":"269","author":"Woo","year":"2022","journal-title":"J. Neurol."},{"issue":"10","key":"10.1016\/j.pdpdt.2025.104632_bib0066","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1007\/s00415-020-09925-x","article-title":"Visual hallucinations and illusions in Parkinson's disease: the role of ocular pathology","volume":"267","author":"Marques","year":"2020","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104632_bib0067","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/alz.12179","article-title":"Retinal imaging in Alzheimer's and neurodegenerative diseases","volume":"17","author":"Snyder","year":"2021","journal-title":"Alzheimers. Dement."},{"issue":"6","key":"10.1016\/j.pdpdt.2025.104632_bib0068","doi-asserted-by":"crossref","first-page":"e3014","DOI":"10.1002\/brb3.3014","article-title":"Optical coherence tomography in patients with Wilson's disease","volume":"13","author":"Ning","year":"2023","journal-title":"Brain Behav."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104632_bib0069","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11011-015-9776-8","article-title":"Optical coherence tomography and electrophysiology of retinal and visual pathways in Wilson's disease","volume":"31","author":"Langwi\u0144ska-Wo\u015bko","year":"2016","journal-title":"Metab. Brain Dis."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104632_bib0070","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/dmcn.14040","article-title":"Optical coherence tomography and magnetic resonance imaging visual pathway evaluation in Wolfram syndrome","volume":"61","author":"Zmyslowska","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104632_bib0071","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF00230925","article-title":"Pattern ERG in the monkey after section of the optic nerve","volume":"59","author":"Maffei","year":"1985","journal-title":"Exp. Brain Res."},{"issue":"6","key":"10.1016\/j.pdpdt.2025.104632_bib0072","first-page":"1124","article-title":"The photopic negative response of the macaque electroretinogram: reduction by experimental glaucoma","volume":"40","author":"Viswanathan","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104632_bib0073","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","article-title":"ISCEV Standard for full-field clinical electroretinography (2022 update)","volume":"144","author":"Robson","year":"2022","journal-title":"Doc. Ophthalmol."},{"issue":"1","key":"10.1016\/j.pdpdt.2025.104632_bib0074","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","article-title":"ISCEV Standard for full-field clinical electroretinography (2015 update)","volume":"130","author":"McCulloch","year":"2015","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2025.104632_bib0075","doi-asserted-by":"crossref","first-page":"E004","DOI":"10.1017\/S0952523823000032","article-title":"Pre-stimulus bioelectrical activity in light-adapted ERG under blue versus white background","volume":"40","author":"Tsay","year":"2023","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.pdpdt.2025.104632_bib0076","doi-asserted-by":"crossref","first-page":"E004","DOI":"10.1017\/S0952523824000038","article-title":"Electroretinographic responses to periodic stimuli in primates and the relevance for visual perception and for clinical studies","volume":"41","author":"Kremers","year":"2024","journal-title":"Vis. Neurosci."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104632_bib0077","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/brain\/101.4.661","article-title":"Measurements of visual evoked potentials in Parkinson's disease","volume":"101","author":"Bodis-Wollner","year":"1978","journal-title":"Brain"},{"issue":"Pt 5","key":"10.1016\/j.pdpdt.2025.104632_bib0078","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awp068","article-title":"Burn DJ. The retina in Parkinson's disease","volume":"132","author":"Archibald","year":"2009","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.pdpdt.2025.104632_bib0079","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10072-006-0522-1","article-title":"Chromatic pattern-reversal electroretinograms (ChPERGs) are spared in multiple system atrophy compared with Parkinson's disease","volume":"26","author":"Sartucci","year":"2006","journal-title":"Neurol. Sci."},{"issue":"12","key":"10.1016\/j.pdpdt.2025.104632_bib0080","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1212\/01.wnl.0000191565.11065.11","article-title":"Visual dysfunction in Parkinson disease without dementia","volume":"65","author":"Uc","year":"2005","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.pdpdt.2025.104632_bib0081","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/jnnp.49.10.1150","article-title":"Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans","volume":"49","author":"Onofrj","year":"1986","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"12","key":"10.1016\/j.pdpdt.2025.104632_bib0082","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1007\/s10439-023-03365-0","article-title":"Retina Oculomics in neurodegenerative disease","volume":"51","author":"Suh","year":"2023","journal-title":"Ann. Biomed. Eng."},{"issue":"16","key":"10.1016\/j.pdpdt.2025.104632_bib0083","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93621","article-title":"Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease","volume":"2","author":"Koronyo","year":"2017","journal-title":"JCI. Insight."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104632_bib0084","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10633-010-9238-x","article-title":"Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer's disease","volume":"121","author":"Krasodomska","year":"2010","journal-title":"Doc. Ophthalmol."},{"issue":"8","key":"10.1016\/j.pdpdt.2025.104632_bib0085","article-title":"Retinal dysfunction in Alzheimer's Disease and implications for","volume":"11","author":"Liao","year":"2021","journal-title":"Biomarkers. Biomol."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104632_bib0086","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1212\/CPJ.0000000000001041","article-title":"Role of optical coherence tomography in identifying retinal biomarkers in frontotemporal dementia: a review","volume":"11","author":"Moinuddin","year":"2021","journal-title":"Neurol. Clin. Pract."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104632_bib0087","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3233\/JAD-160886","article-title":"Optical coherence tomography reveals retinal neuroaxonal thinning in frontotemporal dementia as in Alzheimer's Disease","volume":"56","author":"Ferrari","year":"2017","journal-title":"J. Alzheimers. Dis."},{"issue":"15","key":"10.1016\/j.pdpdt.2025.104632_bib0088","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0000000000004500","article-title":"Optical coherence tomography identifies outer retina thinning in frontotemporal degeneration","volume":"89","author":"Kim","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.pdpdt.2025.104632_bib0089","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fnins.2019.00298","article-title":"Persistent and progressive outer retina thinning in frontotemporal degeneration","volume":"13","author":"Kim","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pdpdt.2025.104632_bib0090","article-title":"Combination of multifocal electroretinogram and spectral-domain OCT can increase diagnostic efficacy of Parkinson's Disease","volume":"2018","author":"Huang","year":"2018","journal-title":"Parkinsons. Dis."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104632_bib0091","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10072-018-3244-2","article-title":"Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson's disease","volume":"39","author":"Unlu","year":"2018","journal-title":"Neurol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.pdpdt.2025.104632_bib0092","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jns.2015.05.007","article-title":"Characterization of retinal architecture in Parkinson's disease","volume":"355","author":"Chorostecki","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104632_bib0093","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1167\/iovs.13-13062","article-title":"Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity","volume":"55","author":"Garcia-Martin","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104632_bib0094","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1080\/08820538.2017.1307423","article-title":"Evaluation of choroidal and retinal thickness changes in Parkinson's Disease using spectral domain optical coherence tomography","volume":"33","author":"Moschos","year":"2018","journal-title":"Semin. Ophthalmol."},{"issue":"4","key":"10.1016\/j.pdpdt.2025.104632_bib0095","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/acn3.46","article-title":"Subtle retinal pathology in amyotrophic lateral sclerosis","volume":"1","author":"Ringelstein","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104632_bib0096","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/ijo.IJO_1870_22","article-title":"Retinal nerve fiber layer thinning found in amyotrophic lateral sclerosis - correlation with disease duration and severity","volume":"71","author":"Mohanty","year":"2023","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2025.104632_bib0097","article-title":"Selective and inverse U-shaped curve alteration of the retinal nerve in amyotrophic lateral sclerosis: a potential mirror of the disease","volume":"13","author":"Zhang","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104632_bib0098","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00702-015-1483-4","article-title":"Retinal involvement in amyotrophic lateral sclerosis: a study with optical coherence tomography and diffusion tensor imaging","volume":"123","author":"H\u00fcbers","year":"2016","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"7","key":"10.1016\/j.pdpdt.2025.104632_bib0099","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00415-018-8863-2","article-title":"Reduced retinal nerve fiber layer (RNFL) thickness in ALS patients: a window to disease progression","volume":"265","author":"Rohani","year":"2018","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104632_bib0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10633-018-9632-3","article-title":"Retinal dysfunction in a presymptomatic patient with Huntington's disease","volume":"136","author":"Knapp","year":"2018","journal-title":"Doc. Ophthalmol."},{"issue":"6","key":"10.1016\/j.pdpdt.2025.104632_bib0101","doi-asserted-by":"crossref","first-page":"e2592","DOI":"10.1002\/brb3.2592","article-title":"No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onset","volume":"12","author":"Schmid","year":"2022","journal-title":"Brain Behav."},{"issue":"3","key":"10.1016\/j.pdpdt.2025.104632_bib0102","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/mds.26486","article-title":"Spectral-domain optical coherence tomography as a potential biomarker in Huntington's Disease","volume":"31","author":"Andrade","year":"2016","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.pdpdt.2025.104632_bib0103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282175","article-title":"Is retina affected in Huntington's disease? Is optical coherence tomography a good biomarker?","volume":"18","author":"Dusek","year":"2023","journal-title":"PLoS One"}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100025001644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100025001644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T08:17:43Z","timestamp":1756714663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100025001644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":103,"alternative-id":["S1572100025001644"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2025.104632","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review and network meta-analysis of retinal imaging biomarkers in neurodegenerative diseases: Correlation with brain changes","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2025.104632","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104632"}}